Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Red Nucleus
Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion
3.1 Summary of Evidence 3.1.1 Study Characteristics Table 1 presents detailed characteristics of the ten additional studies identified in the updated searches; quality assessment results are in Table S5 of the ESM. Details of the 20 previously identified studies are reported in Dams et al. [11].
EE383 ARCHITECTURE OF RARE-DISEASE MODELS: STRUCTURAL CHOICES AND CLINICAL TRIAL ENDPOINT USE IN NICE HST EVALUATIONS
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
EE312 HEALTH ECONOMICS PUBLISHED EVIDENCE FOR FDA-APPROVED DRUGS (2022-2023): AVAILABILITY, TIMING & DISSEMINATION PATHWAY
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
HPR69 2026 REVIEW OF GENE THERAPY ACCESS LANDSCAPE
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
HPR85 REVIEW OF CELL THERAPY ACCESS LANDSCAPE
As more cell therapies have been developed and approved in the United States during the past few years, their high costs may impact payer budgets and create patient access challenges. This research aims to evaluate emerging trends in price and payer coverage of cell therapies in the United States.
Red Nucleus Named to the 2026 MM+M Agency 100
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
Townhall
Deal enhances existing value, evidence, and market access solutions as demand for economic and outcomes services accelerates Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial, and learning & development, today announced that it has acquired Bridge Medical Consulting, a specialized health economics and outcomes research (HEOR) consultancy.
Red Nucleus Announces Acquisition of Coeus
www.cablinginstall.comis using a security service for protection against online attacks. The service requires full JavaScript support in order to view this website. Please enable JavaScript on your browser and try again.
Red Nucleus Announces Acquisition of Coeus
Strategic Investment Enhances Red Nucleus’ Market Access Services Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial solutions, and learning and development, today announced that it has acquired COEUS, a multi-specialty, commercially aligned consultancy offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients.
Red Nucleus Announces Majority Investment from THL Partners
Red Nucleus ( "the Company"), a leading provider of strategic services across research and development, medical affairs, market access, and learning and development, today announced that it has received a majority investment from THL Partners ("THL"), a premier private equity firm investing in middle market growth companies. The strategic partnership will help broaden the Company's suite of commercialization services for its global customer base. This press release features multimedia.
6 SEPTEMBER FREEFIRE TONIGHT UPDATE+6 SEPTEMBER FREE REWARD|FF NEW EVENT| TONIGHT UPDATE|6 SEP EVENT
Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!
Red Nucleus Announces Acquisition of COEUS
This page will host Events plug-in for all Clarion and trade events.
Red Nucleus ("RN") Acquires Human Element Solutions, LLC ("element H")
Red Nucleus expands service offerings with acquisition of first-rate provider of creative content and experiences for life sciences.
Red Nucleus Acquires Yukon Training, Provider of Essential Skills Training
Red Nucleus expands its learning capabilities with provider of online modules, off-the-shelf content, and workshops , /PRNewswire-PRWeb/ -- Red Nucleus, a premier provider of strategic learning and development (L&D), scientific services and advisory (SS&A), and medical communications solutions exclusively for the life sciences industry, announced that it has acquired Yukon Training ("Yukon"), a leading provider of online modules, off-the-shelf content, and workshops focused on the biopharma...
Red Nucleus Acquires Medical Marketing Solutions Group ("MMSG")
YARDLEY, Pa., Feb.9, 2022 /PRNewswire-PRWeb/ --Red Nucleus ("RN"), a premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry, announced that it has acquired Medical Marketing Solutions Group ("MMSG"), a leading provider of strategic services, scientific communication, and operational and event management services to biopharmaceutical companies and brands, with its primary focus in...
Red Nucleus Acquires Medical Marketing Solutions Group ("MMSG")
YARDLEY, Pa., Feb.9, 2022 /PRNewswire-PRWeb/ --Red Nucleus ("RN"), a premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry, announced that it has acquired Medical Marketing Solutions Group ("MMSG"), a leading provider of strategic services, scientific communication, and operational and event management services to biopharmaceutical companies and brands, with its primary focus in...
Red Nucleus Acquires PPM Advisory Group and OrtleyBio
YARDLEY, Pa., April 15, 2021 /PRNewswire-PRWeb/ -- Red Nucleus ("RN"), a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired PPM Advisory Group and OrtleyBio (collectively "PPM"), a leading provider of scientific operations and communications services to biopharmaceutical companies and brands, with its primary focus in oncology and hematology therapeutic areas.
Red Nucleus Acquires iTakeControl
YARDLEY, Pa., March 4, 2021 /PRNewswire-PRWeb/ -- Red Nucleus ("RN"), a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired iTakeControl ("ITC"), a leading provider of clinical operations and medical affairs technology and services focused on rare disease and specialty pharma.
INVIVO Communications Joins Red Nucleus
YARDLEY, Pa. and TORONTO, Sept. 30, 2020 /PRNewswire/ -- Red Nucleus ("RN"), a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired INVIVO Communications ("INVIVO"), a leading digital scientific communications agency. The INVIVO deal positions Red Nucleus as a differentiated life science firm, grounded in commercial education, clinical operations, R&D process, and now scientific communications.
INVIVO Communications Joins Red Nucleus
YARDLEY, Pa. and TORONTO, Sept. 30, 2020 /PRNewswire/ -- Red Nucleus ("RN"), a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired INVIVO Communications ("INVIVO"), a leading digital scientific communications agency. The INVIVO deal positions Red Nucleus as a differentiated life science firm, grounded in commercial education, clinical operations, R&D process, and now scientific communications.
The Exhibition at eyeforpharma Barcelona
“Earth Trek, based in Osaka, Japan, with branch offices and factories in Hong Kong, Ningbo, Shenzhen and Zhongshan, China. With over 20 years of experience,…” Earth Trek, based in Osaka, Japan, with branch offices and factories in Hong Kong, Ningbo, Shenzhen and Zhongshan, China. With over 20 years of experience, our services range from product planning, development and manufacturing. We work with multinational pharmaceutical companies and local hospitals.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Red
Contact Red, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack